Circulating microRNAs are promising novel biomarkers of acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Internal medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.50.5129PMID 21881276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts.

  2011cited by this paper
• Circulating microRNAs: novel biomarkers for cardiovascular diseases

  2011cited by this paper
• MiR423-5p As a Circulating Biomarker for Heart Failure

  2010cited by this paper
• Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction.

  2010cited by this paper
• Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans.

  2010influential reference
• Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer

  2010cited by this paper
• Circulating microRNAs: novel biomarkers for cardiovascular diseases?

  2010cited by this paper
• Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

  2010cited by this paper
• Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas

  2010cited by this paper
• MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation

  2010influential reference
• MicroRNAs miR-1, miR-133a, miR-133b and miR-208 Are Dysregulated in Human Myocardial Infarction

  2009cited by this paper
• MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1*

  2009cited by this paper
• MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells

  2009cited by this paper
• Circulating microRNAs, potential biomarkers for drug-induced liver injury

  2009cited by this paper
• Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction.

  2009cited by this paper
• Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

  2008cited by this paper
• The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure

  2008cited by this paper
• Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart.

  2008cited by this paper
• Control of cardiac excitability by microRNAs.

  2008cited by this paper
• Right into the heart of microRNA-133a.

  2008cited by this paper
• MicroRNA miR-328 Regulates Zonation Morphogenesis by Targeting CD44 Expression

  2008cited by this paper
• MicroRNAs: role in cardiovascular biology and disease.

  2008cited by this paper
• Down-regulation of miR-1/miR-133 Contributes to Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart*♦

  2008cited by this paper
• Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

  2008cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• MicroRNA-133 controls cardiac hypertrophy

  2007cited by this paper
• MicroRNA miR-133 Represses HERG K+ Channel Expression Contributing to QT Prolongation in Diabetic Hearts*

  2007cited by this paper
• Retracted: Transcriptional activation by stimulating protein 1 and post‐transcriptional repression by muscle‐specific microRNAs of IKs‐encoding genes and potential implications in regional heterogeneity of their expressions

  2007cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• The diverse functions of microRNAs in animal development and disease.

  2006cited by this paper
• Cardiac troponins and renal function in nondialysis patients with chronic kidney disease.

  2005cited by this paper
• Diagnostic Efficiency of Troponin T Measurements in Acute Myocardial Infarction

  1991cited by this paper

• MicroRNAs as potential biomarkers and future therapeutic targets in thrombosis: from molecular mechanisms to clinical implications.

  2026cites this paper
• Beneficial and challenges of exosome application in ischemic heart disease

  2025cites this paper
• Plasma Extracellular MicroRNAs Associated With Cardiovascular Disease Risk Factors in Middle‐Aged and Older Adults

  2024cites this paper
• DNA methylation in cardiovascular disease and heart failure: novel prediction models?

  2024cites this paper
• Trials and Tribulations of MicroRNA Therapeutics

  2024cites this paper
• Quantitative proteomics of the miR-301a/SOCS3/STAT3 axis reveals underlying autism and anxiety-like behavior

  2024cites this paper
• Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction

  2024cites this paper
• Pathological roles of miRNAs and pseudogene-derived lncRNAs in human cancers, and their comparison as prognosis/diagnosis biomarkers.

  2023cites this paper
• Precision Medicine Approach to Stress Testing Using Metabolomics and

  2023cites this paper
• Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer—Advances and Challenges

  2023cites this paper
• MicroRNA in medication related osteonecrosis of the jaw: a review

  2023cites this paper
• Differential Expression of Circulating Damage-Associated Molecular Patterns in Patients with Coronary Artery Ectasia

  2023cites this paper
• Potential clinical and biochemical markers for the prediction of drug-resistant epilepsy: A literature review.

  2022influential citation
• Dissecting miRNA–Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine

  2022cites this paper
• Functional Role of microRNAs in Regulating Cardiomyocyte Death

  2022cites this paper
• A precision medicine approach to stress testing using metabolomics and microribonucleic acids.

  2022cites this paper
• Leveraging Extracellular Non-coding RNAs to Diagnose and Treat Heart Diseases

  2022cites this paper
• Epigenetic Regulation of Autophagy in Cardiovascular Pathobiology

  2021cites this paper
• The Role of miRNAs in Extracellular Matrix Repair and Chronic Fibrotic Lung Diseases

  2021cites this paper
• Exploring diagnostic and prognostic predictive values of microRNAs for acute myocardial infarction

  2021cites this paper
• Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics

  2021cites this paper
• miRNA miRNA on the Wall, Who Is the Most Cardio-Specific of Them All? Circulating microRNAs as Potential Biomarkers in Acute Coronary Syndrome

  2021influential citation
• DIAGNOSTIC PROGNOSTIC AND THERAPEUTIC ROLE OF MICRORNA IN CARDIOVASCULAR DISEASES

  2021cites this paper
• Size Doesn’t Matter, Performance Does: Assessing Micro-Ribonucleic Acids as Potent Cardio-Specific Biomarkers in Acute Coronary Syndrome

  2021cites this paper
• Potential Applications and Functional Roles of Exosomes in Cardiometabolic Disease

  2021cites this paper
• Research on the circular RNA bioinformatics in patients with acute myocardial infarction

  2020cites this paper
• MicroRNAs in Cardiovascular Disease.

  2020cites this paper
• Coding and non-coding transcriptome of mesial temporal lobe epilepsy: Critical role of small non-coding RNAs.

  2020cites this paper
• Noncoding RNAs as Biomarkers for Acute Coronary Syndrome

  2020cites this paper
• The Role of MicroRNAs in Regulating Cytokines and Growth Factors in Coronary Artery Disease: The Ins and Outs

  2020cites this paper
• Value of Blood-Based microRNAs in the Diagnosis of Acute Myocardial Infarction: A Systematic Review and Meta-Analysis

  2020cites this paper
• Non-coding RNAs in Cardiovascular Diseases

  2020cites this paper
• MicroRNA and Cardiovascular Diseases

  2020cites this paper
• A Precision Medicine Approach to Stress Testing Using Metabolomics and Microribonucleic Acids

  2020cites this paper
• The Diagnostic Value of Mir-133a in ST Elevation and Non-ST Elevation Myocardial Infarction: A Meta-Analysis

  2020influential citation
• Silencing of lncRNA ZFAS1 protects against hypoxia/reoxygenation-induced injury in HL-1 cells through targeting the miR-761/CDIP1 axis.

  2020cites this paper
• Circulating MicroRNAs: Biogenesis and Clinical Significance in Acute Myocardial Infarction

  2020cites this paper
• Knockdown of circular RNA circMAT2B reduces oxygen-glucose deprivation-induced inflammatory injury in H9c2 cells through up-regulating miR-133

  2020cites this paper
• Altered microRNA dynamics in acute coronary syndrome

  2020cites this paper
• Translational Potential of Non-coding RNAs for Cardiovascular Disease.

  2020cites this paper
• Circulating microRNA in cardiovascular disease.

  2019cites this paper
• Non-coding RNAs regulating cardiac muscle mass.

  2019cites this paper
• Circulating biomarkers in classical Hodgkin lymphoma

  2019cites this paper
• MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients—A Systematic Review

  2019cites this paper
• Circulating miRNAs in Successful and Unsuccessful Aging. A mini-review.

  2019cites this paper
• Expression profiling and bioinformatics analysis of circulating microRNAs in patients with acute myocardial infarction

  2019cites this paper
• Role of Cardio-Specific Micro-Ribonucleic Acids and Correlation with Cardiac Biomarkers in Acute Coronary Syndrome: A Comprehensive Systematic Review

  2019influential citation
• Epigenetic Modification in Coronary Atherosclerosis: JACC Review Topic of the Week.

  2019cites this paper
• The Potential for microRNA Therapeutics and Clinical Research

  2019cites this paper
• Role of circulating miRNAs in the pathophysiology of CVD: As a potential biomarker

  2018cites this paper
• Biomarqueurs transcriptomiques sanguins des maladies cardiovasculaires

  2018cites this paper
• Prognostic Value of MicroRNAs in Coronary Artery Diseases: A Meta-Analysis

  2018cites this paper
• Non-coding RNAs as biomarkers for acute myocardial infarction

  2018cites this paper
• Intra-individual variation of miRNA expression levels in human plasma samples

  2018cites this paper
• miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges

  2018cites this paper
• Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy

  2018influential citation
• Epigenetic biomarkers in cardiovascular disease

  2018cites this paper
• Nuclear Transcription Factor Kappa B (NF-кB) and Molecular Damage Mechanisms in Acute Cardiovascular Diseases. A Review

  2018cites this paper
• MicroRNAs and Myocardial Infarct: Investigating the Controversial Role of Second Generation Biomarkers.

  2017cites this paper
• Identification of microRNAs as diagnostic biomarkers for acute myocardial infarction in Asian populations

  2017cites this paper
• Effects of Polyphenols on Oxidative Stress-Mediated Injury in Cardiomyocytes

  2017cites this paper
• Circulating microRNAs and Bioinformatics Tools to Discover Novel Diagnostic Biomarkers of Pediatric Diseases

  2017cites this paper
• Transcriptomic profiling of platelet senescence and platelet extracellular vesicles

  2017cites this paper
• Extracellular MicroRNAs Induce Potent Innate Immune Responses via TLR7/MyD88-Dependent Mechanisms

  2017cites this paper
• Stem cell therapy for ischemic heart diseases.

  2017cites this paper
• A meta-analysis of the relations between blood microRNA-208b detection and acute myocardial infarction.

  2017cites this paper
• MicroRNA-133 mediates cardiac diseases: Mechanisms and clinical implications.

  2017cites this paper
• Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects

  2016influential citation
• Tiny Shuttles for Information Transfer: Exosomes in Cardiac Health and Disease

  2016cites this paper
• Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review

  2016cites this paper
• Epigenetic associations in relation to cardiovascular prevention and therapeutics

  2016cites this paper
• Acute Response of Circulating Vascular Regulating MicroRNAs during and after High-Intensity and High-Volume Cycling in Children

  2016cites this paper
• MicroRNAs: A Link Between Type 1 Diabetes and the Environment?

  2016cites this paper
• Evaluating Diagnostic and Prognostic Value of Plasma miRNA133a in Acute Chest Pain Patients Undergoing Coronary Angiography

  2016cites this paper
• [Epigenetics in atherosclerosis].

  2016cites this paper
• Circulating microRNAs as Biomarkers in Cardiovascular Diseases.

  2015cites this paper
• The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment.

  2015cites this paper
• Clinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction

  2015cites this paper
• Noncoding RNA in age-related cardiovascular diseases

  2015cites this paper
• Novel methodologies for biomarker discovery in atherosclerosis.

  2015cites this paper
• Circulating miR-765 and miR-149: Potential Noninvasive Diagnostic Biomarkers for Geriatric Coronary Artery Disease Patients

  2015cites this paper
• Exosomes for Intramyocardial Intercellular Communication

  2015cites this paper
• Expression of circulating microRNAs in patients with ST segment elevation acute myocardial infarction.

  2015cites this paper
• Serum microRNAs as biomarker for active and latent tuberculosis infection in immunocompetent and immunodeficient hosts

  2015cites this paper
• MicroRNAs in cardiovascular disease: an introduction for clinicians

  2015cites this paper
• Circulating MicroRNAs as Biomarkers

  2015cites this paper
• MicroRNAs in platelet function and cardiovascular disease

  2015cites this paper
• microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.

  2015cites this paper
• Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study).

  2015cites this paper
• Gene Expression Signatures and the Spectrum of Coronary Artery Disease

  2015cites this paper
• Les microARN : biomarqueurs et cibles thérapeuthiques des maladies cardiovasculaires

  2014cites this paper
• Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease

  2014cites this paper
• MiRNAs as Biomarkers of Myocardial Infarction: A Meta-Analysis

  2014influential citation
• Remote Ischemic Preconditioning Preserves Mitochondrial Function and Influences Myocardial MicroRNA Expression in Atrial Myocardium During Coronary Bypass Surgery

  2014cites this paper
• Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction

  2014cites this paper
• Methodological challenges in utilizing miRNAs as circulating biomarkers

  2014cites this paper
• Novel Insights into miRNA in Lung and Heart Inflammatory Diseases

  2014cites this paper
• MicroRNAs Expression Profiles in Cardiovascular Diseases

  2014cites this paper
• Circulating miR-1, miR-133a, and miR-206 levels are increased after a half-marathon run

  2014cites this paper
• Targeting microRNAs for cardiovascular therapeutics in coronary artery disease

  2014cites this paper